Home
Search
Placeholder Banner
Amicus Brief

BIO Submits Amicus Brief in Sandoz Inc. v. Amgen Manufacutring Inc. and Amgen Manufacturing Ltd v. Sandoz Inc. (U.S. Supreme Court)

March 17, 2017

BIO submitted an amicus brief in Sandoz Inc. v. Amgen Inc. and Amgen Manufacturing Limited, as well as Amgen Inc. and Amgen Manufacturing Limited v. Sandoz Inc., at the Supreme Court of the United States.

As one of the leading proponents for the creation of a biosimilar approval pathway that also maintains incentives for innovation, BIO has a strong interest in the proper implementation of this statutory scheme by the courts.

Related Resources
15-1039-15-1195-bsac-Biotechnology-Innovation-Organization 0
Download
15-1039-15-1195-bsac-Biotechnology-Innovation-Organization
BIO Amgen v. Sandoz Brief (SCOTUS)
Download
Discover More
BIO Files Amicus Brief in California Supreme…
BIO filed an amicus brief in the Supreme Court of the State of California, encouraging its review of the lower court decision in the Gilead Tenofovir Cases.The Court of Appeal decision operates from a misunderstanding of the drug development and FDA…
Learn more
BIO files Amicus Brief in Colorado PDAB Case
The Biotechnology Innovation Organization (“BIO”) respectfully moves the Court for leave to file an amicus brief in support of Plaintiffs’ response in opposition to the Defendants’ cross-motion for summary judgment. Copies of the proposed brief and…
Learn more
BIO Files Amicus Brief in Continuing Effort to…
BIO filed an amicus brief in a continuing effort to challenge courts' decisions that undermine FDA authority and hinder patient access to medications.The brief was filed in the Supreme Court of the United States (SCOTUS), following the August 2023…
Learn more